VTGN - Vistagen Therapeutics Inc.
IEX Last Trade
3.49
-0.030 -0.860%
Share volume: 45,027
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.52
-0.03
-0.85%
Summary score
28%
Profitability
43%
Dept financing
25%
Liquidity
25%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-55.78%
Return on assets
-66.41%
Return on sales
-211.01%
Return on invested capital
726.75%
Total debt ratio
100.83%
Debt ratio change over timeo
-0.9%
Current Ratio
3.48%
Quick Ratio
0%
Cash Position Ratio
3.13%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
95.78%
Return on assets
-66.19%
Return on sales
0%
Return on invested capital
2121.85%
Total debt ratio
186.54%
Debt ratio change over timeo
-1.31%
Current Ratio
0.75%
Quick Ratio
0%
Cash Position Ratio
0.6%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
61.7%
Return on assets
-50.62%
Return on sales
0%
Return on invested capital
-263.34%
Total debt ratio
191%
Debt ratio change over time
-1.76%
Current Ratio
0.82%
Quick Ratio
0%
Cash Position Ratio
0.58%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-134.03%
Return on assets
-113.72%
Return on sales
-206.06%
Return on invested capital
-118.96%
Total debt ratio
-89.54%
Debt ratio change over time
-0.9%
Current Ratio
-0%
Quick Ratio
0%
Cash Position Ratio
-0.1%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VTGN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -55.78% | -3.05% | 11.55% | 6.27% |
| Return on assets | -66.41% | 3.6% | 3.57% | 5.27% |
| Return on sales | -211.01% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 726.75% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 36% | 67% | 59% |
| Total debt ratio | 100.83% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.9% | 6.09% | 6.03% | 1.53% |
| Dept financing | 25% | 50% | 43% | 14% |
| Current Ratio | 0.75% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 0.6% | 1.48% | 0.76% | 1.49% |
| Liquididy | 49% | 26% | 54% | 58% |
| Short-term ratios | VTGN | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 95.78% | -25.62% | 17.94% | 7.14% |
| Return on assets | -66.19% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 2121.85% | 8.14% | 7.17% | 18.16% |
| Profitability | 50% | 38% | 49% | 49% |
| Total debt ratio | 186.54% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.31% | -23.44% | 9.66% | 0.6% |
| Dept financing | 25% | 14% | 36% | 5% |
| Current Ratio | 0.75% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 0.6% | 1.48% | 0.76% | 1.49% |
| Liquididy | 15% | 57% | 42% | 75% |